CompletedNot Applicable

Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK

United Kingdom587 participantsStarted 2012-10

Plain-language summary

This study aims to assess the risk of solid organ transplant (SOT) rejection following vaccination with Pandemrix™ and/ or seasonal influenza vaccination.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subject defined as acceptable in the CPRD GOLD. * Subject with at least one solid organ transplant rejection reported in the CPRD GOLD and/or HES during the overall study periods (01 September 2006 to 31 October 2010). Exclusion Criteria: • Subject from HES matched to more than one subject in the CPRD GOLD.

What they're measuring

Assessment of the risk of solid organ transplant rejection (liver, kidney, lung, heart, pancreas).

Timeframe: Within one month after vaccination with Pandemrix™ (from 01 October 2009 to 31 October 2010).

Trial details

NCT IDNCT01715792

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2013-08

View on ClinicalTrials.gov More Influenza trials